Apogee Therapeutics, Inc.
APGE • NASDAQ
Apogee Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Thomas Henderson, with a market cap of $5.8B.
Market Cap$5.8B
Employees91.0
CEOMichael Thomas Henderson
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Apogee Therapeutics, Inc. FAQ
Common questions about Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026.
Apogee Therapeutics, Inc. has approximately 91 employees.